Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset

American Journal of Public Health

Volumn 88, Issue 9, 1998, Pages 1337-1342

  Brookmeyer, Ron ^a   Gray, Sarah ^a   Kawas, Claudia ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COST; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; ONSET AGE; PREVALENCE; UNITED STATES;

EID: 0031695197     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.9.1337     Document Type: Article

References (56)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E-type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
2. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994; 44:227-232.
3. Breitner JC, Welsh KA, Helms MJ, et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging. 1995;16: 523-530.
4. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk of Alzheimer's disease? Neurology. 1995;45: 1441-1445.
5. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology. 1994;44:2073-2080.
6. Stewart W, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAIDs use. Neurology. 1997;48:626-632.
7. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn NE, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 1994;51:896-900.
8. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994;140:256-261.
9. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med. 1996;156:2213-2217.
10. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517-1521.
11. Tang MX, Jacobs D, Stern Y, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996; 348:429-432.
12. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology. 1990;40:1698-1707.
13. Martin G, Kukull W. Do cultural differences affect Alzheimer's disease? JAMA 1996;276: 993-995.
14. White L, Petrovitdi H, Ross G, et al. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. JAMA. 1996;276:955-960.
15. Jorm AF. Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. Eur Arch Psychiatry Clin Neurosci. 1991;240:218-222.
16. Van Duijn CM. Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry. 1996;60: 478-488.
17. Bachman DL, Wolfe PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993;43:515-519.
18. Hebert L, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995;273: 1343-1359.
19. Kokmen E, Chandra V, Schoenberg BS. Trends in incidence of dementing illness in Rochester, Minnesota in three quinquennial periods. Neurology. 1988;38:975-980.
20. Shock N, Greulich R, Andres R, et al. Normal Human Aging: The Baltimore Longitudinal Study of Aging. Washington, DC: US Government Printing Office; 1984. NIH publication 84-2450.
21. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: American Psychiatric Association; 1987.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
23. Lautenschlager NT, Cupples LA, Rao VS, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology. 1996;46:641-650.
24. Fratiglioni L, Viitanen M, Von Strauss E, Tontodonati V, Herlitz A, Wisblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48:132-138.
25. Historical Statistics of the United States, Colonial Times to 1970. Washington, DC: US Bureau of the Census; 1975.
26. Vital Statistics of the United States, 1955-1958. Vol. 1. Washington, DC: Public Health Service; 1957-1960.
27. Vital Statistics of the United States, 1959. Vol. 1. Washington, DC: Public Health Service; 1962.
28. Vital Statistics of the United States, 1960-1991, Vol. 2. Washington, DC: Public Health Service; 1963-1996.
29. Kochanek KD, Hudson BL. Advance report of final mortality statistics, 1992. Month Vital Stat Rep. 1995;43(6)(suppl).
30. Gardner P, Hudson BL. Advance report of final mortality statistics, 1993. Month Vital Stat Rep. 1996;44(7)(suppl).
31. Singh GK, Kochanek KD, MacDorman MF. Advance report of final mortality statistics, 1994. Month Vital Stat Rep. 1996;45(3)(suppl).
32. Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein H, Albert LE. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol. 1991; 134:403-412.
33. United States Census Bureau national population projections. Available at: http://www.census.gov/pub/population/projections/nation. Accessed December 19, 1996.
34. Day JC. Population Projections of the United States by Age, Sex, and Hispanic Origin: 1995 to 2050. Washington, DC: US Bureau of the Census; 1996. Current Population Reports P25-1130.
35. Stern Y, Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer's disease. JAMA. 1997; 277:806-812.
36. Ernst RL, Hay JW. The U.S. economic and social costs of Alzheimer's disease revisited. Am J Public Health. 1994;84:1261-1264.
37. Rice DP, Fox PJ, Max W, et al. The economic burden of Alzheimer's disease care. Health Aff. 1993;12:165-176.
38. Evans DA, Scherr PA, Cook NR, et al. Estimating prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267-289.
39. Evans DA, Scherr PA, Cook NR. The impact of Alzheimer's disease in the United States population. In: Suzman R, Willis D, Manton KG, eds. The Oldest Old. New York, NY: Oxford University Press Inc; 1992.
40. Small GW, Rabins P, Barry P, et al. Diagnosis and treatment of Alzheimer's disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA. 1997;278:1363-1371.
41. Nilsson LV. Incidence of severe dementia in an urban sample followed from 70-79 years of age. Acta Psychiatr Scand. 1984;70:478-486.
42. Rorsman B, Hagnell O, Lanke J. Prevalence and incidence of senile and multi-infarct dementia in the Lundby study: a comparison of time periods 1947-1957 and 1957-1972. Neuropsychobiology. 1986;15:122-129.
43. Letenneur L, Commenges RD, Dartigues JF, Saberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol. 1994;24:1256-1261.
44. Copeland JRM, Davidson IA, Dewey ME, et al. Alzheimer's disease, other dementia, depression and pseudo-dementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry. 1991;161:230-239.
45. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population. The Hisayama study. Neurology. 1995;45:1161-1168.
46. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 1993;43:13-20.
47. Beard CM, Kokmen E, Offord KP, Kurland LT. Lack of association between Alzheimer's disease and education, occupation, marital status or living arrangement. Neurology. 1992;42: 2063-2068.
48. Cobb JL, Wolf PA, Au R, et al. The effect of education in the incidence of dementia and Alzheimer's disease in the Framingham study. Neurology. 1995;45:1707-1712.
49. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-479.
50. Corrada M, Brookmeyer R, Kawas C. Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol. 1995;24:1000-1005.
51. LeBars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA. 1997;278:1327-1332.
52. Thal LJ. Potential prevention strategies for Alzheimer's disease. Alzheimer Dis Assoc Disord. 1996;10:6-8.
53. Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley ACD. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 1992;21:91-94.
54. McGeer PL, Schulzer M, McGeer E. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease. Neurology. 1996;46:425-432.
55. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994;140:262-267.
56. Fourrier A, Letenneur L, Begaud B, Dartigues J. Nonsteroidal anti-inflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. J Clin Epidemiol. 1996;49:1201.